Immunocore Holdings plc (IMCR) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 42 transactions totaling $18.8M, demonstrating a bearish sentiment with -$18.8M in net insider flow. The most recent transaction on Dec 5, 2025 involved a transaction of 572 shares valued at $10.0K.
No significant insider buying has been recorded for IMCR in the recent period.
No significant insider selling has been recorded for IMCR in the recent period.
Based on recent SEC filings, insider sentiment for IMCR is bearish with an Insider Alignment Score of 0/100 and a net flow of -$18.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Immunocore Holdings plc (IMCR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading IMCR stock, having executed 42 transactions in the past 90 days. The most active insider is David M. Berman (Executive), who has made 37 transactions totaling $24.9M.
Get notified when executives and directors at IMCR file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | M. Berman David | Executive | Option Exercise | 572 | $17.46 | $10.0K | |
| Dec 5, 2025 | M. Berman David | Executive | Sale | 572 | $40.14 | $23.0K | |
| Dec 4, 2025 | M. Berman David | Executive | Sale | 31,341 | $40.26 | $1.3M | Large |
| Dec 4, 2025 | M. Berman David | Executive | Option Exercise | 31,341 | $17.46 | $547.2K | Large |
| Nov 28, 2025 | M. Berman David | Executive | Option Exercise | 5,521 | $17.46 | $96.4K | |
| Nov 28, 2025 | M. Berman David | Executive | Sale | 5,521 | $40.09 | $221.3K | |
| Nov 26, 2025 | M. Berman David | Executive | Option Exercise | 69,404 | $17.46 | $1.2M | Large |
| Nov 26, 2025 | M. Berman David | Executive | Sale | 69,404 | $40.12 | $2.8M | Large |
| Nov 25, 2025 | M. Berman David | Executive | Sale | 18,020 | $40.03 | $721.3K | Large |
| Nov 25, 2025 | M. Berman David | Executive | Option Exercise | 18,020 | $17.46 | $314.6K | |
| Nov 24, 2025 | M. Berman David | Executive | Sale | 100 | $40.00 | $4.0K | |
| Nov 24, 2025 | M. Berman David | Executive | Option Exercise | 100 | $17.46 | $1.7K | |
| Sep 30, 2025 | M. Berman David | Executive | Sale | 61,849 | $35.23 | $2.2M | Large |
| Sep 30, 2025 | M. Berman David | Executive | Option Exercise | 61,849 | $17.46 | $1.1M | Large |
| Sep 15, 2025 | M. Berman David | Executive | Option Exercise | 200 | $17.46 | $3.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 26 | $18.8M | 73.2% |
Exercise(M) | 16 | $6.9M | 26.8% |
Insider selling pressure at Immunocore Holdings plc has increased, with 2 insiders executing 42 transactions across all time. Total sales of $18.8M significantly outpace purchases of $0, resulting in a net outflow of $18.8M. However, 43% of these transactions are pre-scheduled 10b5-1 plans, often used for tax planning or diversification rather than signaling negative outlook.